journal article·2024-02-09Open access

Reconstructive Approach in Residual Periodontal Pockets with Biofunctionalized Heterografts—A Retrospective Comparison of 12-Month Data from Three Centers

Anton Friedmann, Pheline Liedloff, Meizi Eliezer, Arthur Brincat, Thomas Ostermann, Daniel Diehl

Abstract

The regenerative capacity of well-preserved blood clots may be enhanced by biologics like enamel matrix derivative (EMD). This retrospective analysis compares outcomes reported by three centers using different heterografts. Center 1 (C1) treated intrabony defects combining cross-linked high-molecular-weight hyaluronic acid (xHyA) with a xenograft; center 2 (C2) used EMD with an allograft combination to graft a residual pocket. Center 3 (C3) combined xHyA with the placement of a resorbable polymer membrane for defect cover. Clinical parameters, BoP reduction, and radiographically observed defect fill at 12-month examination are reported. The 12-month evaluation yielded significant improvements in PPD and CAL at each center (p < 0.001, respectively). Analyses of Covariance revealed significant improvements in all parameters, and a significantly greater CAL gain was revealed for C2 vs. C1 (p = 0.006). Radiographic defect fill presented significantly higher scores for C2 and C3 vs. C1 (p = 0.003 and = 0.014; C2 vs. C3 p = 1.00). Gingival recession increased in C1 and C3 (p = 1.00), while C2 reported no GR after 12 months (C2:C1 p = 0.002; C2:C3 p = 0.005). BoP tendency and pocket closure rate shared similar rates. Within the limitations of the study, a data comparison indicated that xHyA showed a similar capacity to enhance the regenerative response, as known for EMD. Radiographic follow-up underlined xHyA’s unique role in new attachment formation.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Periodontal Regeneration and Treatments · Oral microbiology and periodontitis research · Dental Trauma and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Periodontology, Faculty of Health, Witten/Herdecke University, Alfred-Herrhausen-Str. 50, 58455 Witten, Germany

Independent Researcher, Tel Aviv 3640577, Israel

Independent Researcher, 83000 Toulon, France

Department of Periodontology, Service of Odontology, AP-HM, UFR of Odontology, Aix-Marseille University, 13005 Marseille, France

Department of Psychology, Faculty of Health, Witten/Herdecke University, 58455 Witten, Germany

Institute of Pharmacology and Toxicology, Faculty of Health, Witten/Herdecke University, 58453 Witten, Germany

References (48)

Show source-provided references
1. Immunomicrobial pathogenesis of periodontitis: Keystones, pathobionts, and host response10.1016/j.it.2013.09.001 ↗
2. Focus on intrabony defects–conservative therapy10.1034/j.1600-0757.2000.2220105.x ↗
3. Treatment of stage I–III periodontitis—The EFP S3 level clinical practice guideline10.1111/jcpe.13290 ↗
4. Regenerative surgery versus access flap for the treatment of intra-bony periodontal defects: A systematic review and meta-analysis10.1111/jcpe.13237 ↗
5. Space-providing expanded polytetrafluoroethylene devices define alveolar augmentation at dental implants induced by recombinant human bone morphogenetic protein 2 in an absorbable collagen sponge carrier10.1111/j.1708-8208.2003.tb00192.x ↗
6. Periodontal repair in dogs: A bioabsorbable calcium carbonate coral implant enhances space provision for alveolar bone regeneration in conjunction with guided tissue regeneration10.1902/jop.2003.74.7.957 ↗
7. Pocket resolution in regenerative treatment of intrabony defects with papilla preservation techniques: A systematic review and meta-analysis of randomized clinical trials10.1111/jcpe.13428 ↗
8. Effect of topically applied hyaluronic acid on pain and palatal epithelial wound healing: An examiner-masked, randomized, controlled clinical trial10.1902/jop.2017.170105 ↗
9. Correction to: Effectiveness of adjunctive hyaluronic acid application in coronally advanced flap in Miller class I single gingival recession sites: A randomized controlled clinical trial10.1007/s00784-018-2567-y ↗
10. Healing of buccal gingival recessions following treatment with coronally advanced flap alone or combined with a cross-linked hyaluronic acid gel. An experimental study in dogs10.1111/jcpe.13433 ↗
11. Cross-linked hyaluronic acid-gel with or without a collagen matrix in the treatment of class III furcation defects: A histologic and histomorphometric study in dogs10.1111/jcpe.13694 ↗
12. Pilloni, A., Zeza, B., Kuis, D., Vrazic, D., Domic, T., Olszewska-Czyz, I., Popova, C., Kotsilkov, K., Firkova, E., and Dermendzieva, Y. (2021). Treatment of Residual Periodontal Pockets Using a Hyaluronic Acid-Based Gel: A 12 Month Multicenter Randomized Triple-Blinded Clinical Trial. Antibiotics, 10.10.3390/antibiotics10080924 ↗
13. Božić, D., Ćatović, I., Badovinac, A., Musić, L., Par, M., and Sculean, A. (2021). Treatment of intrabony defects with a combination of hyaluronic acid and deproteinized porcine bone mineral. Materials, 14.10.3390/ma14226795 ↗
14. Fujioka-Kobayashi, M., Müller, H.-D., Mueller, A., Lussi, A., Sculean, A., Schmidlin, P.R., and Miron, R.J. (2017). In vitro effects of hyaluronic acid on human periodontal ligament cells. BMC Oral Health, 17.10.1186/s12903-017-0341-1 ↗
15. Nobis, B., Ostermann, T., Weiler, J., Dittmar, T., and Friedmann, A. (2022). Impact of cross-linked hyaluronic acid on osteogenic differentiation of SAOS-2 cells in an air-lift model. Materials, 15.10.3390/ma15196528 ↗
16. Hakki, S.S., Bozkurt, S.B., Sculean, A., and Božić, D. (2023). Hyaluronic acid enhances cell migration, viability, and mineralized tissue-specific genes in cementoblasts. J. Periodontal Res.10.1111/jre.13201 ↗
17. Caton, J.G., Armitage, G., Berglundh, T., Chapple, I.L.C., Jepsen, S., Kornman, K.S., Mealey, B.L., Papapanou, P.N., Sanz, M., and Tonetti, M.S. (2018). A new classification scheme for periodontal and peri-implant diseases and conditions–Introduction and key changes from the 1999 classification. J. Clin. Periodontol.10.1111/jcpe.12935 ↗
18. Clinical concepts for regenerative therapy in intrabony defects10.1111/prd.12048 ↗
19. The effect of hyaluronan on mouse intramembranous osteogenesis in vitro10.1007/s004410051182 ↗
20. Hyaluronic acid as a bioactive component for bone tissue regeneration: Fabrication, modification, properties, and biological functions10.1515/ntrev-2020-0084 ↗
21. Role of hyaluronan in regulating self-renewal and osteogenic differentiation of mesenchymal stromal cells and pre-osteoblasts10.1007/s00784-020-03259-8 ↗
22. The molecular weight of hyaluronic acid influences metabolic activity and osteogenic differentiation of periodontal ligament cells10.1007/s00784-023-05202-z ↗
23. Hyaluronic acid-based extracellular matrix triggers spontaneous M2-like polarity of monocyte/macrophage10.1039/C9BM00155G ↗
24. Glycosaminoglycans enhance osteoblast differentiation of bone marrow derived human mesenchymal stem cells10.1002/term.1507 ↗
25. Periodontal wound healing/regeneration of two-wall intrabony defects following reconstructive surgery with cross-linked hyaluronic acid-gel with or without a collagen matrix: A preclinical study in dogs
26. Treatment of infrabony periodontal defects using a resorbable biopolymer of hyaluronic acid: A randomized clinical trial
27. Interaction of enamel matrix proteins with human periodontal ligament cells10.1007/s00784-015-1510-8 ↗
28. Enamel matrix derivative (EMD) enhances the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs)10.1080/21655979.2021.1971504 ↗
29. Sordi, M.B., Cabral da Cruz, A.C., Panahipour, L., and Gruber, R. (2022). Enamel matrix derivative decreases pyroptosis-related genes in macrophages. Int. J. Mol. Sci., 23.10.3390/ijms23095078 ↗
30. Enamel matrix derivative: Protein components and osteoinductive properties10.1902/jop.2013.130264 ↗
31. Treatment of intrabony defects with enamel matrix proteins or barrier membranes: Results from a multicenter practice-based clinical trial10.1902/jop.2004.75.5.726 ↗
32. Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration10.1111/j.1600-051X.2008.01295.x ↗
33. Clinical and histologic evaluation of an enamel matrix derivative combined with a biphasic calcium phosphate for the treatment of human intrabony periodontal defects10.1902/jop.2008.080009 ↗
34. A multi-centre randomized controlled clinical trial on the treatment of intra-bony defects with enamel matrix derivatives/synthetic bone graft or enamel matrix derivatives alone: Results after 12 months10.1111/j.1600-051X.2011.01726.x ↗
35. Efficacy of enamel matrix derivative with freeze-dried bone allograft or demineralized freeze-dried bone allograft in intrabony defects: A randomized trial10.1902/jop.2014.130520 ↗
36. Enamel matrix derivative and bone grafts for periodontal regeneration of intrabony defects. A systematic review and meta-analysis10.1007/s00784-015-1491-7 ↗
37. Regeneration of periodontal tissues: Combinations of barrier membranes and grafting materials–biological foundation and preclinical evidence: A systematic review10.1111/j.1600-051X.2008.01263.x ↗
38. Design of biocomposite materials for bone tissue regeneration10.1016/j.msec.2015.07.016 ↗
39. Bone graft substitutes currently available in orthopaedic practice: The evidence for their use10.1302/0301-620X.95B5.30286 ↗
40. Friedmann, A., Fickl, S., Fischer, K.R., Dalloul, M., Goetz, W., and Kauffmann, F. (2021). Horizontal augmentation of chronic mandibular defects by the Guided Bone Regeneration approach: A randomized study in dogs. Materials, 15.10.3390/ma15010238 ↗
41. Guided tissue regeneration therapy of 203 consecutively treated intrabony defects using a bioabsorbable matrix barrier. Clinical and radiographic findings10.1902/jop.1997.68.6.571 ↗
42. Long-term stability of periodontal conditions achieved following guided tissue regeneration with bioresorbable membranes: Case series results after 6–7 years10.1111/j.1600-051X.2004.00586.x ↗
43. The role of non-steroidal anti-inflammatory drugs as adjuncts to periodontal treatment and in periodontal regeneration10.1186/s12967-023-03990-2 ↗
44. The effect of indomethacin on alveolar bone loss in experimental periodontitis10.1111/j.1600-0765.1982.tb01134.x ↗
45. Flurbiprofen: A potent inhibitor of alveolar bone resorption in beagles10.1126/science.3969553 ↗
46. Gingival crevicular fluid prostaglandin E2 and thiobarbituric acid reactive substance levels in smokers and non-smokers with chronic periodontitis following phase I periodontal therapy and adjunctive use of flurbiprofen10.1902/jop.2007.060217 ↗
47. Nibali, L., Buti, J., Barbato, L., Cairo, F., Graziani, F., and Jepsen, S. (2021). Adjunctive effect of systemic antibiotics in regenerative/reconstructive periodontal surgery—A systematic review with meta-analysis. Antibiotics, 11.10.3390/antibiotics11010008 ↗
48. Mechanism and biological significance of CD44 cleavage10.1111/j.1349-7006.2004.tb03179.x ↗